Original language | English |
---|---|
Number of pages | 0 |
Journal | Multiple Sclerosis and Related Disorders |
Volume | 63 |
Issue number | 0 |
Early online date | 27 May 2022 |
DOIs | |
Publication status | Published - Jul 2022 |
Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)
Ruth Dobson*, Matthew Craner, Ed Waddingham, Aleisha Miller, Jayant Pindoria, Ana Cavey, Camilla Blain, Luca G De, Nikos Evangelou, Helen Ford, Paul Gallagher, Katila George, Ramos Dias R Geraldes, Paula Harman, Jeremy Hobart, Tanya King, Ruth Linighan, Niall MacDougall, Monica Marta, Stephanie Mitchell
*Corresponding author for this work
- Queen Mary University of London
- Royal London Hospital
- Frimley Health NHS Foundation Trust
- John Radcliffe Hospital
- Imperial College London
- St. George's University Hospital
- Nottingham University Hospitals NHS Trust
- Leeds Teaching Hospitals NHS Trust
- Queen Elizabeth University Hospital, Glasgow
- Southend Hospital
- University Hospitals Plymouth NHS Trust
- Institute of Neurological Sciences
- NHS Lanarkshire
- Northern Care Alliance NHS Group
- Charing Cross Hospital
- Southmead Hospital NHS Trust
- University of Bristol
- The Walton Centre NHS Foundation Trust
Research output: Contribution to journal › Article › peer-review
12
Downloads
(Pure)